Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
10:01am, Thursday, 09'th Apr 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, Apr
Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
10:01am, Thursday, 09'th Apr 2020
RANCHO CUCAMONGA, April 09, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and...
AQR Capital Management LLC Sells 1,567 Shares of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)
08:34am, Thursday, 09'th Apr 2020
AQR Capital Management LLC lessened its stake in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) by 3.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Com
Liquidia Technologies (LQDA) Gets a Buy Rating from Needham
02:53pm, Wednesday, 08'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Liquidia Technologies (LQDA) today and set a price target of $30.00. The company's shares closed
Liquidia Technologies (LQDA) Gets a Buy Rating from Needham
02:53pm, Wednesday, 08'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) today and set a price
Needham Remains a Buy on KalVista Pharmaceuticals (KALV)
05:10pm, Tuesday, 07'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on KalVista Pharmaceuticals (KALV) today and set a price target of $28.00. The company's shares
Needham Remains a Buy on KalVista Pharmaceuticals (KALV)
05:10pm, Tuesday, 07'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price
We Wouldn’t Rely On Amphastar Pharmaceuticals’s (NASDAQ:AMPH) Statutory Earnings As A Guide
10:41am, Tuesday, 07'th Apr 2020
Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...
Head-To-Head Analysis: Amphastar Pharmaceuticals (NASDAQ:AMPH) and Neurotrope (NASDAQ:NTRP)
06:02am, Tuesday, 07'th Apr 2020
Amphastar Pharmaceuticals (NASDAQ:AMPH) and Neurotrope (NASDAQ:NTRP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of
Needham Thinks GW Pharma's Stock is Going to Recover
05:17pm, Monday, 06'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on GW Pharma (GWPH), with a price target of $190.00. The company's shares
Needham Thinks GW Pharma’s Stock is Going to Recover
05:17pm, Monday, 06'th Apr 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on GW Pharma (GWPH – Research Report),
$81.66 Million in Sales Expected for Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) This Quarter
06:46am, Saturday, 04'th Apr 2020
Wall Street analysts forecast that Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) will report sales of $81.66 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates
Needham Thinks Aerie Pharma's Stock is Going to Recover
01:16pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last
Needham Thinks Aerie Pharma’s Stock is Going to Recover
01:16pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price
Collegium Pharmaceutical (COLL) Receives a Buy from Needham
12:56pm, Friday, 03'rd Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Collegium Pharmaceutical (COLL) today and set a price target of $38.00. The company's shares
